Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence
Caponnetto, S., Gelibter, A., Mosillo, C., Magri, V., Scagnoli, S., Pomati, G., Piesco, G., Verkhovskaya, S., Pisegna, S., Sirgiovanni, G., Napoli, V., Buscicchio, D., Iannantuono, G.M., Marinelli, D., Mammone, G., Pannunzio, S., Nicolo', E., Stefani, A., Astorino, V., Mancini, M., Cortesi, E.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
254P Development of machine learning models for the prediction of early progression (EP) to first-line (1L) cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) therapy in oestrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC)
Pannunzio, S., Mastrantoni, L., Pontolillo, L., Garufi, G., Di Monte, E., Maliziola, N., Pasqualoni, M., Palazzo, A., Orlandi, A., Tortora, G., Bria, E.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article